Kenvue Q1 2026 net sales rise 4.5% to $3.9 billion; EPS $0.25; no guidance
Kenvue reported first-quarter 2026 net sales of $3.9 billion, up 4.5% from a year earlier, and diluted EPS of $0.25 versus $0.17. Organic sales grew only 0.7%, with a 3.8% foreign currency benefit driving much of the increase. The company will not provide forward-looking guidance because of its pending transaction with Kimberly-Clark, which it expects to close in the second half of 2026.
Key points
- Net sales were $3.9 billion, up 4.5%; organic sales rose 0.7% and foreign currency added 3.8%.
- Diluted EPS was $0.25 vs $0.17; adjusted diluted EPS was $0.32 vs $0.24.
- Operating income margin was 19.6% vs 14.9%; no forward guidance is being provided due to the pending Kimberly-Clark transaction.
The filing
Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.